These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

946 related articles for article (PubMed ID: 17414038)

  • 1. Indications for and outcomes of mastoid obliteration in cochlear implantation.
    Leung R; Briggs RJ
    Otol Neurotol; 2007 Apr; 28(3):330-4. PubMed ID: 17414038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indications for middle ear obliteration within the scope of cochlear implant management].
    Issing PR; Schönermark M; Kempf HG; Lenarz T
    Laryngorhinootologie; 1996 Dec; 75(12):727-31. PubMed ID: 9081277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma.
    Vercruysse JP; De Foer B; Somers T; Casselman JW; Offeciers E
    Otol Neurotol; 2008 Oct; 29(7):953-60. PubMed ID: 18719515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
    Kim CW; Oh JI; Choi KY; Park SM; Park MI
    Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of subtotal petrosectomy in cochlear implant surgery--a report of 32 cases and review on indications.
    Free RH; Falcioni M; Di Trapani G; Giannuzzi AL; Russo A; Sanna M
    Otol Neurotol; 2013 Aug; 34(6):1033-40. PubMed ID: 23856625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obliteration of the persistently discharging mastoid cavity using the middle temporal artery flap.
    Singh V; Atlas M
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):433-8. PubMed ID: 17765771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experience with beta-tricalcium phosphate for use in mastoid cavity obliteration after mastoidectomy.
    Minoda R; Hayashida M; Masuda M; Yumoto E
    Otol Neurotol; 2007 Dec; 28(8):1018-21. PubMed ID: 17898672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canal wall reconstruction tympanomastoidectomy with mastoid obliteration.
    Gantz BJ; Wilkinson EP; Hansen MR
    Laryngoscope; 2005 Oct; 115(10):1734-40. PubMed ID: 16222186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochlear implantation in patients with chronic otitis media.
    Kojima H; Sakurai Y; Rikitake M; Tanaka Y; Kawano A; Moriyama H
    Auris Nasus Larynx; 2010 Aug; 37(4):415-21. PubMed ID: 20189327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active middle ear implants in patients undergoing subtotal petrosectomy: new application for the Vibrant Soundbridge device and its implication for lateral cranium base surgery.
    Linder T; Schlegel C; DeMin N; van der Westhuizen S
    Otol Neurotol; 2009 Jan; 30(1):41-7. PubMed ID: 18849883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear implantation in patients with chronic suppurative otitis media.
    Wong MC; Shipp DB; Nedzelski JM; Chen JM; Lin VY
    Otol Neurotol; 2014 Jun; 35(5):810-4. PubMed ID: 24569796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of central asymmetry in speech processing on selecting the ear for cochlear implantation.
    Morris LG; Mallur PS; Roland JT; Waltzman SB; Lalwani AK
    Otol Neurotol; 2007 Jan; 28(1):25-30. PubMed ID: 17195742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suprameatal approach: a safe alternative surgical technique for cochlear implantation.
    Postelmans JT; Tange RA; Stokroos RJ; Grolman W
    Otol Neurotol; 2010 Feb; 31(2):196-203. PubMed ID: 20009783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical cavities and cochlear implantation.
    Hamzavi J; Baumgartner W; Franz P; Plenk H
    Acta Otolaryngol; 2001 Jul; 121(5):607-9. PubMed ID: 11583394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochlear implantation after canal wall down mastoidectomy - Outcomes after partial mastoid obliteration.
    Balk M; Schwarz D; Wolber P; Anagiotos A; Gostian AO
    Auris Nasus Larynx; 2019 Aug; 46(4):487-492. PubMed ID: 30442436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochlear implantation in patients with chronic otitis media and radical mastoidectomy: A single-stage procedure.
    Piché M; Côté M; Philippon D; Laflamme N; Bussières R
    Rev Laryngol Otol Rhinol (Bord); 2014; 135(4-5):175-80. PubMed ID: 26521364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative to canal wall-down mastoidectomy for sclerotic mastoid cavities: epitympanoplasty with mastoid obliteration.
    Heo KW; Kang MK; Park JY
    Ann Otol Rhinol Laryngol; 2014 Jan; 123(1):47-52. PubMed ID: 24574423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard cochlear implantation of adults with residual low-frequency hearing: implications for combined electro-acoustic stimulation.
    Novak MA; Black JM; Koch DB
    Otol Neurotol; 2007 Aug; 28(5):609-14. PubMed ID: 17514064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration.
    Yanagihara N; Komori M; Hinohira Y
    Otol Neurotol; 2009 Sep; 30(6):766-70. PubMed ID: 19704361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.